Charles Lu

TCGADEPMAP – Mapping Translational Dependencies and Synthetic Lethalities within The Cancer Genome Atlas

Andy H. Vo, Z. Dezső, M. Flister, 2022, bioRxiv.

Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapy

J. Waring, S. Stilgenbauer, M. Davids, 2021, American journal of hematology.

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

A. Letai, Jing Wang, M. Konopleva, 2022, Signal Transduction and Targeted Therapy.

A genome-wide CRISPR screen supported by human genetics identifies the TNRC18 gene locus as a novel regulator of inflammatory signaling

A. D. den Hollander, Kanstantsin V. Katlinski, F. Rahimov, 2023, bioRxiv.

Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

A. Letai, M. Konopleva, M. Andreeff, 2022, Signal Transduction and Targeted Therapy.